Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting 2026-07-27 · last update 2026-07-27
Manufacturers: GlaxoSmithKline
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22) | GlaxoSmithKline | To Be Discontinued | — | The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available. | Posted 07/27/2026 Updated 07/27/2026 Discontinued 07/27/2026 |
| Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22) | GlaxoSmithKline | To Be Discontinued | — | The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available. | Posted 07/27/2026 Updated 07/27/2026 Discontinued 07/27/2026 |
| Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22) | GlaxoSmithKline | To Be Discontinued | — | The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available. | Posted 07/27/2026 Updated 07/27/2026 Discontinued 07/27/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)